Promoting Transparency and Healthy Competition in Medicare Act

HR 8260 Hospital Inpatient Services Modernization Act H.R. 8235 the Rural Physician Workforce Preservation Act H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act HR 3171/S. 3018 The Improving Seniors Timely Access to Care Act H.R. 1110, KEEP Telehealth Options Act of 2023 H.R. 3875, Expanded Telehealth Access Act H.R. 5541, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act H.R. 5611, Helping Ensure Access to Local TeleHealth (HEALTH) Act of 2023 H.R. 6033, Supporting Patient Education And Knowledge (SPEAK) Act of 2023 H.R. 7149, Equal Access to Specialty Care Everywhere (EASE) Act of 2024 H.R. 7623, The Telehealth Modernization Act of 2024 H.R. 7711, To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program H.R. 7858, Telehealth Enhancement for Mental Health Act of 2024 H.R. 7863, To require the Secretary of Health and Human Services to issue guidance on furnishing behavioral health services via telehealth to individuals with limited English proficiency under Medicare program H.R. 5386, Cutting Copays Act H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage H.R. 5372, Expanding Seniors Access to Lower Cost Medicines Act of 2023 S. 3059 the REAL Health Provider Act (Bennet, Tillis) S. 2973 Modernizing and Ensuring PBM Accountability Act H.R. 2880, the Protecting Patients Against PBM Abuses Act S.1002 - No UPCODE Act H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act H.R. 3284, the Providers and Payers COMPETE Act H.R. 3237, To amend title XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each outpatient department Legislation and regulation related to the Medicare Advantage program and Medicare/Medicaid coverage, care delivery and financing.

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 1967, the Patients Before Middlemen (PBM) Act, establishing new requirements relating to the responsibility of pharmacy benefit managers under Medicare part D; H.R. 3282, Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3284, Providers and Payers COMPETE Act, To require the Secretary of Health and Human Services to consider, within the annual rulemaking process, the effect of regulatory changes to certain Medicare payment systems on provider and payer consolidation, and for other purposes; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 5376, the Share the Savings with Seniors Act; H.R. 5385, the Medicare PBM Accountability Act; H.R.4881, To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program. Including issues related to point-of-sale rebates in Part D Low-Income Subsidy under the Medicare program; H.R. 5393, the Transparency and Fairness for Pharmacies Act; H.R. 5372, the Expanding Seniors Access to Lower Cost Medicines Act of 2023; H.R. 1352, the Increasing Access to Biosimilars Act; H.R. 5386, the Cutting Copays Act; Issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule; H.R. 7623, Telehealth Modernization Act of 2024; H.R. 8702/ S.4532, Improving Seniors' Timely Access to Care Act.

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770 / S. 2477, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; S. 2405, the Strengthening Pharmacy Access for Seniors Act; S. 2973, the Modernizing and Ensuring PBM Accountability Act; H.R. 5378, the Lower Costs, More Transparency Act; H.R.5385, the Medicare PBM Accountability Act; H.R. 5393, to amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes; H.R. 5400 / S. 2436, the NO PBMs Act; S.3430,the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023; Request for Information for "Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program in the Inflation Reduction Act" (IRA; P.L. 117-169); Comments for "Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025" (IRA, P.L. 117-169); Comments for Final Rule Document 2022-09375, "Medicare Program, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs..." (87 FR 27704); Comments for "Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies" (CMS-2024-0006); Request for Information for Bipartisan 340B Senate Working Group SUSTAIN 340B Act Discussion Draft; H.R.4366, the Consolidated Appropriations Act, 2024 H.R.2882, the Further Consolidated Appropriations Act, 2024 Cybersecurity protocols and policies in health care system and the impact on claims processing and reimbursement; Comments to CMS on the implementation of Medicare Part D vaccine coverage under the Inflation Reduction Act (IRA; P.L. 117-169); Comments to CMMI on the Importance of Implementing Reasonable Reimbursement Guardrails for Pharmacies in the Medicare $2 Drug List Model based on the Executive Order on Lowering Prescription Drug Costs for Americans; Comments to HHS and CMS on 2024 NADAC Methodology Changes; Comment to CMS on "Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027."; H.R. 9096, the Pharmacists Fight Back Act; Long Term Care at Home Pharmacy Services in Medicare; Regulating fair and common-sense contracting guardrails between Part D plans/PBMs, and pharmacies; Comments to CMS on Proposed Rule Re: Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments [CMS-1807-P]; H.R.4758, the Accelerating Kids Access to Care Act; H.R. 8107, the Ensuring Access to Medicaid Buy-in Programs Act of 2024; Comments to CMS on Draft Guidance Re: Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027;

S. 1967, the Patients Before Middlemen (PBM) Act, establishing new requirements relating to the responsibility of pharmacy benefit managers under Medicare part D; H.R. 3282, Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3284, Providers and Payers COMPETE Act, To require the Secretary of Health and Human Services to consider, within the annual rulemaking process, the effect of regulatory changes to certain Medicare payment systems on provider and payer consolidation, and for other purposes; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 5376, the Share the Savings with Seniors Act; H.R. 5385, the Medicare PBM Accountability Act; H.R.4881, To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program. Including issues related to point-of-sale rebates in Part D Low-Income Subsidy under the Medicare program; H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage; H.R. 5393, the Transparency and Fairness for Pharmacies Act; H.R. 5372, the Expanding Seniors Access to Lower Cost Medicines Act of 2023; H.R. 1352, the Increasing Access to Biosimilars Act; H.R. 5386, the Cutting Copays Act; Issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule; H.R. 7623, Telehealth Modernization Act of 2024; H.R./ S. Improving Seniors' Timely Access to Care Act.

H.R. 8235 the Rural Physician Workforce Preservation Act H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act HR 3171/S. 3018 The Improving Seniors Timely Access to Care Act H.R. 1110, KEEP Telehealth Options Act of 2023 H.R. 3875, Expanded Telehealth Access Act H.R. 5541, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act H.R. 5611, Helping Ensure Access to Local TeleHealth (HEALTH) Act of 2023 H.R. 6033, Supporting Patient Education And Knowledge (SPEAK) Act of 2023 H.R. 7149, Equal Access to Specialty Care Everywhere (EASE) Act of 2024 H.R. 7623, The Telehealth Modernization Act of 2024 H.R. 7711, To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program H.R. 7858, Telehealth Enhancement for Mental Health Act of 2024 H.R. 7863, To require the Secretary of Health and Human Services to issue guidance on furnishing behavioral health services via telehealth to individuals with limited English proficiency under Medicare program H.R. 5386, Cutting Copays Act H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage H.R. 5372, Expanding Seniors Access to Lower Cost Medicines Act of 2023 S. 3059 the REAL Health Provider Act (Bennet, Tillis) S. 2973 Modernizing and Ensuring PBM Accountability Act H.R. 2880, the Protecting Patients Against PBM Abuses Act S.1002 - No UPCODE Act H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act H.R. 3284, the Providers and Payers COMPETE Act H.R. 3237, To amend title XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each outpatient department Legislation and regulation related to the Medicare Advantage program and Medicare/Medicaid coverage, care delivery and financing.

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770 / S. 2477, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; S. 2405, the Strengthening Pharmacy Access for Seniors Act; S. 2973, the Modernizing and Ensuring PBM Accountability Act; H.R. 5378, the Lower Costs, More Transparency Act; H.R.5385, the Medicare PBM Accountability Act; H.R. 5393, to amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes; H.R. 5400 / S. 2436, the NO PBMs Act; S.3430,the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023; Request for Information for "Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program in the Inflation Reduction Act" (IRA; P.L. 117-169); Comments for "Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025" (IRA, P.L. 117-169); Comments for Final Rule Document 2022-09375, "Medicare Program, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs..." (87 FR 27704); Comments for "Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies" (CMS-2024-0006); Request for Information for Bipartisan 340B Senate Working Group SUSTAIN 340B Act Discussion Draft; H.R.4366, the Consolidated Appropriations Act, 2024 H.R.2882, the Further Consolidated Appropriations Act, 2024 Cybersecurity protocols and policies in health care system and the impact on claims processing and reimbursement; Comments to CMS on the implementation of Medicare Part D vaccine coverage under the Inflation Reduction Act (IRA; P.L. 117-169); Comments to CMMI on the Importance of Implementing Reasonable Reimbursement Guardrails for Pharmacies in the Medicare $2 Drug List Model based on the Executive Order on Lowering Prescription Drug Costs for Americans; Comments to HHS and CMS on 2024 NADAC Methodology Changes; Comment on "Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027.";

H.R. 1110, KEEP Telehealth Options Act of 2023 H.R. 3875, Expanded Telehealth Access Act H.R. 5541, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act H.R. 5611, Helping Ensure Access to Local TeleHealth (HEALTH) Act of 2023 H.R. 6033, Supporting Patient Education And Knowledge (SPEAK) Act of 2023 H.R. 7149, Equal Access to Specialty Care Everywhere (EASE) Act of 2024 H.R. 7623, The Telehealth Modernization Act of 2024 H.R. 7711, To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program H.R. 7858, Telehealth Enhancement for Mental Health Act of 2024 H.R. 7863, To require the Secretary of Health and Human Services to issue guidance on furnishing behavioral health services via telehealth to individuals with limited English proficiency under Medicare program H.R. 5386, Cutting Copays Act H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage H.R. 5372, Expanding Seniors Access to Lower Cost Medicines Act of 2023 S. 3059 the REAL Health Provider Act (Bennet, Tillis) S. 2973 Modernizing and Ensuring PBM Accountability Act H.R. 2880, the Protecting Patients Against PBM Abuses Act S.1002 - No UPCODE Act H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act H.R. 3284, the Providers and Payers COMPETE Act H.R. 3237, To amend title XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each outpatient department Legislation and regulation related to the Medicare Advantage program and Medicare/Medicaid coverage, care delivery and financing.

Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

S. 1967, the Patients Before Middlemen (PBM) Act, establishing new requirements relating to the responsibility of pharmacy benefit managers under Medicare part D; H.R. 3282, Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3284, Providers and Payers COMPETE Act, To require the Secretary of Health and Human Services to consider, within the annual rulemaking process, the effect of regulatory changes to certain Medicare payment systems on provider and payer consolidation, and for other purposes; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 5376, the Share the Savings with Seniors Act; H.R. 5385, the Medicare PBM Accountability Act; H.R.4881, To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program. Including issues related to point-of-sale rebates in Part D Low-Income Subsidy under the Medicare program; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage; H.R. 5393, the Transparency and Fairness for Pharmacies Act; H.R. 5372, the Expanding Seniors Access to Lower Cost Medicines Act of 2023; H.R. 1352, the Increasing Access to Biosimilars Act; H.R. 5386, the Cutting Copays Act; S. 3059, the Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act; S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (the Better Act); Issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule.

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770 / S. 2477, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; S. 2405, the Strengthening Pharmacy Access for Seniors Act; S. 2973, the Modernizing and Ensuring PBM Accountability Act; H.R. 5378, the Lower Costs, More Transparency Act; H.R.5385, the Medicare PBM Accountability Act; H.R. 5393, to amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes; H.R. 5400 / S. 2436, the NO PBMs Act; S.3430,the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023; Request for Information for "Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program in the Inflation Reduction Act" (IRA; P.L. 117-169); Comments for "Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025" (IRA, P.L. 117-169); Comments for Final Rule Document 2022-09375, "Medicare Program, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs..." (87 FR 27704); Comments for "Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies" (CMS-2024-0006); Request for Information for Bipartisan 340B Senate Working Group SUSTAIN 340B Act Discussion Draft; H.R.4366, the Consolidated Appropriations Act, 2024 H.R.2882, the Further Consolidated Appropriations Act, 2024

H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Issues related to the Improving Seniors Timely Access to Care Act of 2021; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule; Issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications; S. 1967, the Patients Before Middlemen (PBM) Act, establishing new requirements relating to the responsibility of pharmacy benefit managers under Medicare part D; H.R. 3282, Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3284, Providers and Payers COMPETE Act, To require the Secretary of Health and Human Services to consider, within the annual rulemaking process, the effect of regulatory changes to certain Medicare payment systems on provider and payer consolidation, and for other purposes; Issues related to pharmaceutical affordability and access in Medicare under H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 5376, the Share the Savings with Seniors Act; H.R. 5385, the Medicare PBM Accountability Act; H.R.4881, To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program. Including issues related to point-of-sale rebates in Part D Low-Income Subsidy under the Medicare program; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage; H.R. 5393, the Transparency and Fairness for Pharmacies Act (Reps. Griffith and Carter); H.R. 5372, the Expanding Seniors Access to Lower Cost Medicines Act of 2023; H.R. 1352, the Increasing Access to Biosimilars Act; H.R. 5386, the Cutting Copays Act; S. 3059, The Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act; S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (the Better Act).

Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770 / S. 2477, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; S. 2405, the Strengthening Pharmacy Access for Seniors Act; S. 2973, the Modernizing and Ensuring PBM Accountability Act; H.R. 5378, the Lower Costs, More Transparency Act; H.R.5385, the Medicare PBM Accountability Act; H.R. 5393, to amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes; H.R. 5400 / S. 2436, the NO PBMs Act; S.3430,the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023; Request for Information Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program in the Inflation Reduction Act (IRA; P.L. 117-169)

Client expense: $330,000 · Firm income: Not reported

H.R. 5386, Cutting Copays Act H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage H.R. 5372, Expanding Seniors Access to Lower Cost Medicines Act of 2023 S. 3059 the REAL Health Provider Act (Bennet, Tillis) S. 2973 Modernizing and Ensuring PBM Accountability Act H.R. 2880, the Protecting Patients Against PBM Abuses Act S.1002 - No UPCODE Act H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act H.R. 3284, the Providers and Payers COMPETE Act H.R. 3237, To amend title XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each outpatient department Legislation and regulation related to the Medicare Advantage program and Medicare/Medicaid coverage, care delivery and financing.

Client expense: $1,640,000 · Firm income: Not reported

Health Care Workforce Programs and Policies. H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. S.1403 Medical Student Authorization Act of 2023. All Provisions. S.2840 Bipartisan Primary Care and Health Workforce Act. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions. Potential Grants and Procurement Programs Related to U.S. based manufacturing of Personal Protective Equipment (PPE).

Client expense: $200,000 · Firm income: Not reported

CMS'CY 2024 Advance Notice of Methodological Changes for Medicare Capitation Rates for Part C and Part D Payment Policies. Issues surrounding changes to risk adjustment mechanisms. Nomination of Chief Executive Officer for appointment to the Medicaid and CHIP Payment and Access Commission H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions. H.R. 5013 Value in Health Care Act of 2023. All Provisions. Medicaid Supplemental Payment Technical Assistance

Educare policymakers on issues related to the Improving Seniors Timely Access to Care Act of 2021; S. 1967, the Patients Before Middlemen (PBM) Act, establishing new requirements relating to the responsibility of pharmacy benefit managers under Medicare part D; H.R. 3282, Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3284, Providers and Payers COMPETE Act, To require the Secretary of Health and Human Services to consider, within the annual rulemaking process, the effect of regulatory changes to certain Medicare payment systems on provider and payer consolidation, and for other purposes; Issues related to pharmaceutical affordability and access in Medicare under H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 5376, the Share the Savings with Seniors Act; H.R. 5385, the Medicare PBM Accountability Act; H.R. 5393, the Transparency and Fairness for Pharmacies Act (Reps. Griffith and Carter); H.R. 5372, the Expanding Seniors Access to Lower Cost Medicines Act of 2023; H.R. 1352, the Increasing Access to Biosimilars Act; H.R. 5386, the Cutting Copays Act; and S. the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (the Better Act).

Client expense: Not reported · Firm income: $90,000

S. 2973 Modernizing and Ensuring PBM Accountability Act H.R. 2880, the Protecting Patients Against PBM Abuses Act S.1002 - No UPCODE Act H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act H.R. 3284, the Providers and Payers COMPETE Act H.R. 3237, To amend title XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each outpatient department Legislation and regulation related to the Medicare Advantage program and Medicare/Medicaid coverage, care delivery and financing.

Client expense: $790,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to the Improving Seniors Timely Access to Care Act of 2021. Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule. Issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications. S. 1967, the Patients Before Middlemen (PBM) Act, establishing new requirements relating to the responsibility of pharmacy benefit managers under Medicare part D. H.R. 3282, Promoting Transparency and Healthy Competition in Medicare Act. H.R. 3284, Providers and Payers COMPETE Act, To require the Secretary of Health and Human Services to consider, within the annual rulemaking process, the effect of regulatory changes to certain Medicare payment systems on provider and payer consolidation, and for other purposes. Issues related to pharmaceutical affordability and access in Medicare under H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 5376, the Share the Savings with Seniors Act; H.R. 5385, the Medicare PBM Accountability Act. H.R. 4881, and issues related to point-of-sale rebates in Part D Low-Income Subsidy under the Medicare program. S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act.

Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Pharmacy Benefit Manager (PBM) Reform Pharmacy Direct and Indirect Remuneration (DIR) Reform Pharmacy Reimbursement and Scope of Practice Modernizing and Ensuring PBM Accountability (MEPA) Act, S. 2973 PATIENT Act of 2023, H.R. 3561 Lower Costs, More Transparency Act, H.R. 5378 Transparency and Fairness for Pharmacies Act, H.R. 5393 Neighborhood Options for Patients Buying Medicines (NO PBMs) Act, H.R. 5400/S. 2436 Protect Patient Access to Pharmacies Act, S. 2052 Patients Before Middlemen (PBM) Act, S. 1967 PBM Accountability Act, H.R. 2679 Protecting Patients Against PBM Abuses Act (H.R. 2880) Promoting Transparency and Healthy Competition in Medicare Act (H.R. 3282) Pharmacy Benefit Manager Transparency Act of 2023, S. 127 Drug Price Transparency in Medicaid Act, H.R.1613/S. 1038 Prescription Pricing for the People Act, S. 113 Equitable Community Access to Pharmacist Services Act, H.R. 1770/S. 2477

Client expense: $230,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

CMS'CY 2024 Advance Notice of Methodological Changes for Medicare Capitation Rates for Part C and Part D Payment Policies. Issues surrounding changes to risk adjustment mechanisms. Nomination of Chief Executive Officer for appointment to the Medicaid and CHIP Payment and Access Commission H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions. H.R. 5013 Value in Health Care Act of 2023. All Provisions.

Health Care Workforce Programs and Policies. H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. S.1403 Medical Student Authorization Act of 2023. All Provisions. S.2840 Bipartisan Primary Care and Health Workforce Act. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions.

Client expense: $175,000 · Firm income: Not reported

Issues related to drug pricing, drug shortages, and the drug supply chain, including support for the following bills: the Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), the Pharmacy Benefits Manager Accountability Act (H.R. 2679), and the Promoting Transparency and Healthy Competition in Medicare Act (H.R. 3282). Issues related to COVID-19 response and post-public health emergency recommendations, including telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Issues related to combatting opioid addiction, including support for the following bills: the Fentanyl Safe Testing and Overdose Prevention Act (S. 2569) and the Test Strip Access Act of 2023 (H.R. 4106). Patient access to pharmacist provided vaccinations for COVID/flu/pediatric illnesses, COVID-19 testing, emergency HIV prophylaxis, initiation of oral antivirals for flu/COVID, buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Reauthorization of the Pandemic and All-Hazards Preparedness Act, including recommendations to leverage pharmacists as part of the care team. Patient access to comprehensive reproductive healthcare (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). Issues related to site neutral payments (generally, no specific legislation). The Safety from Violence for Healthcare Employees Act (H.R. 2584/S. 2768), provisions related to ensuring workplace safety for healthcare workers, including pharmacists.

Client expense: $280,000 · Firm income: Not reported

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770 / S. 2477, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; S. 2405, the Strengthening Pharmacy Access for Seniors Act; S. 2973, the Modernizing and Ensuring PBM Accountability Act; H.R. 5378, the Lower Costs, More Transparency Act; H.R.5385, the Medicare PBM Accountability Act; H.R. 5393, to amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes; H.R. 5400 / S. 2436, the NO PBMs Act

Client expense: $360,000 · Firm income: Not reported

H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Issues related to the Improving Seniors Timely Access to Care Act of 2021. Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) Programs proposed rule. Issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies; Medicare Program; Contract Year (CY) 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications. S. 1967, the Patients Before Middlemen (PBM) Act, establishing new requirements relating to the responsibility of pharmacy benefit managers under Medicare part D. H.R. 3282, Promoting Transparency and Healthy Competition in Medicare Act. H.R. 3284, Providers and Payers COMPETE Act, To require the Secretary of Health and Human Services to consider, within the annual rulemaking process, the effect of regulatory changes to certain Medicare payment systems on provider and payer consolidation, and for other purposes.

Client expense: $1,650,000 · Firm income: Not reported

Issues related to drug pricing, drug shortages, and the drug supply chain, including support for the following bills: the Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), the Pharmacy Benefits Manager Accountability Act (H.R. 2679), and the Promoting Transparency and Healthy Competition in Medicare Act (H.R. 3282). Issues related to COVID-19 response and post-public health emergency recommendations, including telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Issues related to combatting opioid addiction (generally, no specific legislation). Patient access to pharmacist provided vaccinations for COVID/flu/pediatric illnesses, COVID-19 testing, Emergency HIV prophylaxis, initiation of oral antivirals for flu/COVID, Buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Reauthorization of the Pandemic and All-Hazards Preparedness Act, including recommendations to leverage pharmacists as part of the care team. Patient access to comprehensive reproductive healthcare (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). Issues related to site neutral payments (generally, no specific legislation).

Client expense: $230,000 · Firm income: Not reported

S.1002 - No UPCODE Act H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act H.R. 3284, the Providers and Payers COMPETE Act H.R. 3237, To amend title XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each outpatient department Legislation and regulation related to the Medicare Advantage program and Medicare/Medicaid coverage, care delivery and financing.

Client expense: $760,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Protect Patient Access to Pharmacies Act, S. 2052 Patients Before Middlemen (PBM) Act, S. 1967 PATIENT Act of 2023, H.R. 3561 Pharmacy Benefits Manager Accountability Act, H.R. 2679 Protecting Patients Against PBM Abuses Act (H.R. 2880) Promoting Transparency and Healthy Competition in Medicare Act (H.R. 3282) Pharmacy Benefit Manager (PBM) Reform Pharmacy Direct and Indirect Remuneration (DIR) Reform Pharmacy Reimbursement and Scope of Practice Pharmacy Benefit Manager Transparency Act of 2023, S. 127 Drug Price Transparency in Medicaid Act, H.R.1613/S. 1038 Prescription Pricing for the People Act, S. 113 Equitable Community Access to Pharmacist Services Act, H.R. 1770

Client expense: $410,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act;

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), White House Office

CMS'CY 2024 Advance Notice of Methodological Changes for Medicare Capitation Rates for Part C and Part D Payment Policies. Issues surrounding changes to risk adjustment mechanisms. Nomination of Chief Executive Officer for appointment to the Medicaid and CHIP Payment and Access Commission H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions.

Client expense: $175,000 · Firm income: Not reported

Health Care Workforce Programs and Policies. H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions.

Client expense: $175,000 · Firm income: Not reported